Preliminary experiments show conolidine could inhibit particular ion channels, cutting down neuronal excitability and limiting suffering signals. This mechanism is particularly pertinent in neuropathic suffering, in which abnormal signaling leads to persistent irritation. Moreover, conolidine appears to affect G protein-coupled receptor (GPCR) path